SYNTAX score II - Authors' reply. - Suppr | 超能文献

SYNTAX score II - Authors' reply.

作者信息

Farooq Vasim, van Klaveren David, Steyerberg Ewout W, Serruys Patrick W

出版信息

Lancet. 2013 Jun 1;381(9881):1899-900. doi: 10.1016/S0140-6736(13)61152-6.

DOI:10.1016/S0140-6736(13)61152-6

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

SYNTAX score II - Authors' reply.

Lancet. 2013 Jun 1;381(9881):1899-900. doi: 10.1016/S0140-6736(13)61152-6.

2

SYNTAX score II.SYNTAX评分II

Lancet. 2013 Jun 1;381(9881):1899. doi: 10.1016/S0140-6736(13)61151-4.

3

ACP Journal Club. SYNTAX score II predicted mortality after PCI or CABG in complex CAD better than SYNTAX score.

Ann Intern Med. 2013 Jul 16;159(2):JC5. doi: 10.7326/0003-4819-159-2-201307160-02005.

4

Risk stratification in 3-vessel coronary artery disease: Applying the SYNTAX Score II in the Heart Team Discussion of the SYNTAX II trial.三支血管冠状动脉疾病的风险分层：在SYNTAX II试验的心脏团队讨论中应用SYNTAX评分II

Catheter Cardiovasc Interv. 2015 Nov 15;86(6):E229-38. doi: 10.1002/ccd.25907. Epub 2015 May 6.

5

The SYNTAX score and SYNTAX-based clinical risk scores.SYNTAX 评分和基于 SYNTAX 的临床风险评分。

Semin Thorac Cardiovasc Surg. 2011 Summer;23(2):99-105. doi: 10.1053/j.semtcvs.2011.08.001.

6

CABG or stents in coronary artery disease: end of the debate?冠状动脉疾病中的冠状动脉搭桥术或支架置入术：争论结束了吗？

Lancet. 2013 Feb 23;381(9867):605-7. doi: 10.1016/S0140-6736(13)60258-5.

7

Individual Long-Term Mortality Prediction Following Either Coronary Stenting or Bypass Surgery in Patients With Multivessel and/or Unprotected Left Main Disease: An External Validation of the SYNTAX Score II Model in the 1,480 Patients of the BEST and PRECOMBAT Randomized Controlled Trials.多支血管病变和/或无保护左主干病变患者行冠状动脉支架置入术或旁路移植术的个体长期死亡率预测：SYNTAX II 评分模型在 BEST 和 PRECOMBAT 随机对照试验 1480 例患者中的外部验证。

JACC Cardiovasc Interv. 2016 Aug 8;9(15):1564-72. doi: 10.1016/j.jcin.2016.04.023.

8

Usefulness of SYNTAX score to select patients with left main coronary artery disease to be treated with coronary artery bypass graft.SYNTAX评分在选择接受冠状动脉旁路移植术治疗的左主干冠状动脉疾病患者中的应用价值。

JACC Cardiovasc Interv. 2009 Aug;2(8):731-8. doi: 10.1016/j.jcin.2009.06.003.

9

The SYNTAX score: usefulness, limitations, and future directions.SYNTAX评分：用途、局限性及未来方向。

J Invasive Cardiol. 2011 Dec;23(12):511-2.

10

Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization.在接受经皮或外科左主干血运重建的患者中，全球风险分类和临床 SYNTAX（经皮冠状动脉介入治疗与紫杉醇和心脏手术之间的协同作用）评分。

JACC Cardiovasc Interv. 2011 Mar;4(3):287-97. doi: 10.1016/j.jcin.2010.10.013.

引用本文的文献

1

The proposed 'concordance-statistic for benefit' provided a useful metric when modeling heterogeneous treatment effects.提出的“获益一致性统计量”在对异质治疗效果建模时提供了一个有用的指标。

J Clin Epidemiol. 2018 Feb;94:59-68. doi: 10.1016/j.jclinepi.2017.10.021. Epub 2017 Nov 11.

2

Balancing idealism with realism to safeguard the welfare of patients: The importance of Heart Team led decision-making in patients with complex coronary artery disease.

Indian Heart J. 2016 Jan-Feb;68(1):1-5. doi: 10.1016/j.ihj.2015.10.385. Epub 2016 Jan 12.